The diagnosis and management of mild cognitive impairment: a clinical review
- PMID: 25514304
- PMCID: PMC4269302
- DOI: 10.1001/jama.2014.13806
The diagnosis and management of mild cognitive impairment: a clinical review
Abstract
Importance: Cognitive decline is a common and feared aspect of aging. Mild cognitive impairment (MCI) is defined as the symptomatic predementia stage on the continuum of cognitive decline, characterized by objective impairment in cognition that is not severe enough to require help with usual activities of daily living.
Objective: To present evidence on the diagnosis, treatment, and prognosis of MCI and to provide physicians with an evidence-based framework for caring for older patients with MCI and their caregivers.
Evidence acquisition: We searched PubMed for English-language articles in peer-reviewed journals and the Cochrane Library database from inception through July 2014. Relevant references from retrieved articles were also evaluated.
Findings: The prevalence of MCI in adults aged 65 years and older is 10% to 20%; risk increases with age and men appear to be at higher risk than women. In older patients with MCI, clinicians should consider depression, polypharmacy, and uncontrolled cardiovascular risk factors, all of which may increase risk for cognitive impairment and other negative outcomes. Currently, no medications have proven effective for MCI; treatments and interventions should be aimed at reducing cardiovascular risk factors and prevention of stroke. Aerobic exercise, mental activity, and social engagement may help decrease risk of further cognitive decline. Although patients with MCI are at greater risk for developing dementia compared with the general population, there is currently substantial variation in risk estimates (from <5% to 20% annual conversion rates), depending on the population studied. Current research targets improving early detection and treatment of MCI, particularly in patients at high risk for progression to dementia.
Conclusions and relevance: Cognitive decline and MCI have important implications for patients and their families and will require that primary care clinicians be skilled in identifying and managing this common disorder as the number of older adults increases in coming decades. Current evidence supports aerobic exercise, mental activity, and cardiovascular risk factor control in patients with MCI.
Figures
Similar articles
-
Screening for Cognitive Impairment in Older Adults: An Evidence Update for the U.S. Preventive Services Task Force [Internet].Rockville (MD): Agency for Healthcare Research and Quality (US); 2020 Feb. Report No.: 19-05257-EF-1. Rockville (MD): Agency for Healthcare Research and Quality (US); 2020 Feb. Report No.: 19-05257-EF-1. PMID: 32129963 Free Books & Documents. Review.
-
Screening for Cognitive Impairment in Older Adults: An Evidence Update for the U.S. Preventive Services Task Force [Internet].Rockville (MD): Agency for Healthcare Research and Quality (US); 2013 Nov. Report No.: 14-05198-EF-1. Rockville (MD): Agency for Healthcare Research and Quality (US); 2013 Nov. Report No.: 14-05198-EF-1. PMID: 24354019 Free Books & Documents. Review.
-
Mini-Mental State Examination (MMSE) for the early detection of dementia in people with mild cognitive impairment (MCI).Cochrane Database Syst Rev. 2021 Jul 27;7(7):CD010783. doi: 10.1002/14651858.CD010783.pub3. Cochrane Database Syst Rev. 2021. PMID: 34313331 Free PMC article.
-
Mild cognitive impairment and its management in older people.Clin Interv Aging. 2015 Apr 10;10:687-93. doi: 10.2147/CIA.S73922. eCollection 2015. Clin Interv Aging. 2015. PMID: 25914527 Free PMC article. Review.
-
The new DSM-5 diagnosis of mild neurocognitive disorder and its relation to research in mild cognitive impairment.Aging Ment Health. 2015 Jan;19(1):2-12. doi: 10.1080/13607863.2014.920303. Epub 2014 Jun 10. Aging Ment Health. 2015. PMID: 24914889
Cited by
-
The association between Chinese adapted MIND diet and cognitive function in Chinese middle-aged and older adults: results from the Chinese Square Dance Cohort.Eur J Nutr. 2024 Nov 23;64(1):22. doi: 10.1007/s00394-024-03522-8. Eur J Nutr. 2024. PMID: 39579171
-
Whole-body vibration elicits 40 Hz cortical gamma oscillations and ameliorates age-related cognitive impairment through hippocampal astrocyte synapses in male rats.Biogerontology. 2024 Nov 15;26(1):11. doi: 10.1007/s10522-024-10154-2. Biogerontology. 2024. PMID: 39546054 Free PMC article.
-
Prolactin deficiency drives diabetes-associated cognitive dysfunction by inducing microglia-mediated synaptic loss.J Neuroinflammation. 2024 Nov 14;21(1):295. doi: 10.1186/s12974-024-03289-z. J Neuroinflammation. 2024. PMID: 39543619 Free PMC article.
-
The Association Between Mild Cognitive Impairment and Physical Function in Older Japanese Adults Aged 75 Years or Older Living in Independent Senior Housing: A Cross-Sectional Study.Healthcare (Basel). 2024 Oct 23;12(21):2106. doi: 10.3390/healthcare12212106. Healthcare (Basel). 2024. PMID: 39517319 Free PMC article.
-
Protocol for a prospective, longitudinal cohort study on the incidence of dementia after the onset of delirium in patients with mild cognitive impairment: MDDCohort (Mild Cognitive Impairment Delirium Dementia).BMC Geriatr. 2024 Nov 7;24(1):922. doi: 10.1186/s12877-024-05480-6. BMC Geriatr. 2024. PMID: 39511473 Free PMC article.
References
-
- McKhann GM, Knopman DS, Chertkow H, et al. The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimer's & dementia : the journal of the Alzheimer's Association. 2011;7(3):263–269. - PMC - PubMed
-
- Albert MS, DeKosky ST, Dickson D, et al. The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimer's & dementia : the journal of the Alzheimer's Association. 2011;7(3):270–279. - PMC - PubMed
-
- Sperling RA, Aisen PS, Beckett LA, et al. Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimer's & dementia : the journal of the Alzheimer's Association. 2011;7(3):280–292. - PMC - PubMed
-
- Institute for Clinical and Economic Review. Diagnostic tests for Alzheimer's disease: generating and evaluating evidence to inform insurance coverage policy. [Accessed August 8, 2014];2012 http://www.icer-review.org/alzheimers/
-
- Centers for Medicare and Medicaid. [Accessed August 8, 2014]; http://www.cms.gov/medicare-coverage-database/details/nca-decision-memo.....
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
